Melanoma News Today

    Skip to content
    • Home
    • About Melanoma
    • Keytruda (Pembrolizumab)
    • Melanoma Clinical Trials
    • Contact Us
    June 12, 2015June 12, 2015

    Provectus Begins Patient Enrolment for Phase 3 Trial of PV-10 for Melanoma

    News
    Provectus Biopharmaceuticals, Inc. a biopharmaceutical company specializing in developing oncology and dermatology therapies, recently announced that a new Phase 3 international FDA comparative clinical study of PV-10 in melanoma treatment has begun patient ... Read more
    June 8, 2015June 9, 2015

    Cancer Drug Increases Collagen in Melanoma

    News
    According to a recent report published in the Matrix Biology Journal titled “The BRAFV600E inhibitor, PLX4032, increases type 1 collagen synthesis in melanoma cells”, collagen presence in the tumor microenvironment can be ... Read more
    June 4, 2015June 5, 2015

    Novel Data On PV-10 For Melanoma Treatment Presented At ASCO

    News
    New findings on PV-10, an investigational intra-lesional therapy for melanoma, were presented during the American Society of Clinical Oncology’s Annual Meeting on May 31, 2015, Chicago, Illinois, USA. The presentation entitled “A Changing Topography: ... Read more
    June 2, 2015

    Genentech’s Investigational Cobimetinib Extends Progression-Free Survival

    News
    Updated data from Genentech’s Phase 3 clinical trial of patients with BRAF V600 mutation-positive advanced melanoma treated with cobimetinib (an investigational MEK inhibitor) in combination with Zelboraf® (vemurafenib) show that ... Read more
    May 31, 2015

    NONO: Key Protein in UV Radiation Response and Cancer Prevention

    News
    A new study published in the journal Oncogene revealed that a protein called NONO plays a crucial role in the cellular response against the detrimental effects of UV radiation in ... Read more
    May 27, 2015

    Melanoma Research Leads NYU Langone Presentations at ASCO 2015

    News
    During the 51st Annual Meeting of the American Society for Clinical Oncology (ASCO), NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center will present nearly 30 abstracts. ... Read more
    May 26, 2015

    Combining Surgery and Ipilimumab Increases Melanoma Patients Survival

    News
    In a new study entitled “Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial” researchers show that advanced stage ... Read more
    May 22, 2015May 22, 2015

    Researchers Discover a Melanoma-Intrinsic Pathway That Blocks Anti-Tumor Immunity

    Melanoma, News
    Researchers at The University of Chicago recently published in the journal Nature the discovery of a melanoma-cell-intrinsic oncogenic pathway that can mediate cancer immune evasion by inhibiting T cells (the primary ... Read more
    May 20, 2015May 20, 2015

    Genentech to Present Melanoma Therapy at ASCO Meeting

    Melanoma, News
    Genentech, a biopharmaceutical firm that is part of the Roche Group, will present over 275 abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting, which is taking place between May 29th ... Read more
    May 18, 2015May 18, 2015

    Novel Anti-Melanoma Antibiotic-Based Strategy Identified in New Study

    News
    A research team at the Roswell Park Cancer Institute in Buffalo found that a previously identified antibiotic has anti-melanoma activity. The study entitled “Pharmacological targeting of guanosine monophosphate synthase suppresses melanoma cell ... Read more
    May 15, 2015May 15, 2015

    Provectus’ Synthesis Patent Granted by Europe and Japan

    Melanoma, News
    Clinical-stage dermatology company Provectus Biopharmaceuticals, which works in the fields of oncology and dermatology, has been granted allowance of its patent application from both the European Patent Office and the Japanese ... Read more
    May 13, 2015May 13, 2015

    DNA Repair Mapped by UNC Researchers

    Melanoma, News
    Groundbreaking work in mapping damaged DNA repair in the human genome reached a milestone at the University of North Carolina School of Medicine and Lineberger Comprehensive Cancer Center. The new ... Read more
    May 11, 2015May 11, 2015

    Cryoport Supports NeoStem’s Intus Study For Metastatic Melanoma Treatment

    Melanoma, News
    New York based biopharmaceutical company, NeoStem, is developing an autologous immunotherapy using patients’ own tumor cells to maximize individuals’ immune system’s ability to identify and eliminate cancer-initiating cells that NeoStem ... Read more
    May 8, 2015May 8, 2015

    Researchers Discover a Promising New Drug Target for Melanoma Treatment

    News
    A team of researchers from The University of North Carolina at Chapel Hill have recently reported the discovery of a new drug target for melanoma treatment. The study was published in ... Read more
    May 6, 2015May 8, 2015

    May is National Melanoma Skin Cancer Prevention Month

    Melanoma, News
    The month of May has been established by the American Academy of Dermatology as National Melanoma Skin Cancer Prevention Month with the goal of raising awareness of melanoma skin cancer and ... Read more
    May 4, 2015May 4, 2015

    Amgen Presents Details Of Biologics License Application For Metastatic Melanoma Drug Talimogene Laherparepvec To Joint FDA Advisory Committee

    Melanoma, News
    A Joint Meeting of the U.S. Food and Drug Administration’s (FDA) Cellular, Tissue and Gene Therapies Advisory Committee (CTGTAC) and Oncologic Drugs Advisory Committee (ODAC) on Wednesday, April 29, 2015 ... Read more
    May 1, 2015May 1, 2015

    Indoor Tanning: More Than A Third Of New Jersey Teens Who Engage In Behavior Do So Frequently

    News, Skin Cancer
    Over a third of New Jersey teenagers practice indoor tanning and, according to a recent study, they do it frequently. Furthermore, those who tan are more likely to be smokers and ... Read more
    April 30, 2015April 30, 2015

    BioNTech Collaborative Study Reveals a Potential New Strategy for Personalized Melanoma, Cancer Immunotherapy

    Melanoma, News
    Biotechnology company BioNTech AG recently announced the publication of a study entitled “Mutant MHC class II epitopes drive therapeutic immune responses to cancer” in the internationally renowned journal Nature. The ... Read more
    April 29, 2015April 29, 2015

    β-catenin Protein Activators Found to be Effective Against Melanoma Cells

    Melanoma, News
    A variety of therapeutic options for melanoma have been developed since 2011, changing the way advanced melanomas are treated. Some treatments focus on specific mutations found in melanoma patients, such as ... Read more
    April 27, 2015April 27, 2015

    Common Skin Mole Mutations Related To Hundreds Of Cancer Possibilities

    Melanoma, News
    An international team of scientists led by Houston Methodist researchers managed to identify in mice models hundreds of possible new genes that might transform benign skin growths into deadly melanomas. These results have been ... Read more

    Posts navigation

    Older posts
    Newer posts

    Never miss another melanoma update.

    * indicates required

    Recent Melanoma Articles

    • clinical trial results

      Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

      June 8, 2017

    • DecisionDx-Melanoma prognosis test

      New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

      June 6, 2017

    • Biothera presents trial results

      Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

      June 1, 2017

    • melanomas that resist immune response

      Researchers Provide New Insights into Melanoma Immune Resistance

      May 30, 2017

    • nevus mole prognosis BGB324

      New Clinical Trial Underway for Treatment of Advanced Melanoma

      May 25, 2017

    You May Also Like…..

    Opdivo, Yervoy Combo Improved Survival in Advanced Melanoma Phase 3 Trial

    April 6, 2017

    Opdivo, Yervoy combination

    Researchers Link Alcohol Consumption to Risk of Developing Invasive Melanoma

    December 13, 2016

    Alcohol consumption and melanoma

    Expert Panel Recommends National Guidelines to Improve Melanoma Screening

    March 28, 2017

    melanoma screening guidelines
    Visit Melanoma News Today's profile on Pinterest.
    Bionews, Inc.
    3 W Garden St
Suite 700
Pensacola, FL 32502
Email: [email protected]
Phone: +1-800-936-1363

    Recent Posts

    • clinical trial results

      Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

      June 8, 2017

    • DecisionDx-Melanoma prognosis test

      New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

      June 6, 2017

    • Biothera presents trial results

      Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

      June 1, 2017

    • melanomas that resist immune response

      Researchers Provide New Insights into Melanoma Immune Resistance

      May 30, 2017

    • About Melanoma News Today
    • Contact Us
    • Terms of Service
    • Privacy Policy

    Disclaimer:

    Melanoma News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
    Copyright © 2013-2025 All rights reserved.